RT Journal Article
SR Electronic
T1 Characterization of long-term patient-reported symptoms of COVID-19: an analysis of social media data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.13.21260449
DO 10.1101/2021.07.13.21260449
A1 Banda, Juan M.
A1 Adderley, Nicola
A1 Ahmed, Waheed-Ul-Rahman
A1 AlGhoul, Heba
A1 Alser, Osaid
A1 Alser, Muath
A1 Areia, Carlos
A1 Cogenur, Mikail
A1 Fišter, Krisitina
A1 Gombar, Saurabh
A1 Huser, Vojtech
A1 Jonnagaddala, Jitendra
A1 Lai, Lana YH
A1 Leis, Angela
A1 Mateu, Lourdes
A1 Mayer, Miguel Angel
A1 Minty, Evan
A1 Morales, Daniel
A1 Natarajan, Karthik
A1 Paredes, Roger
A1 Periyakoil, Vyjeyanthi S.
A1 Prats-Uribe, Albert
A1 Ross, Elsie G.
A1 Singh, Gurdas
A1 Subbian, Vignesh
A1 Vivekanantham, Arani
A1 Prieto-Alhambra, Daniel
YR 2021
UL http://medrxiv.org/content/early/2021/07/15/2021.07.13.21260449.abstract
AB As the SARS-CoV-2 virus (COVID-19) continues to affect people across the globe, there is limited understanding of the long term implications for infected patients1–3. While some of these patients have documented follow-ups on clinical records, or participate in longitudinal surveys, these datasets are usually designed by clinicians, and not granular enough to understand the natural history or patient experiences of ‘long COVID’. In order to get a complete picture, there is a need to use patient generated data to track the long-term impact of COVID-19 on recovered patients in real time. There is a growing need to meticulously characterize these patients’ experiences, from infection to months post-infection, and with highly granular patient generated data rather than clinician narratives. In this work, we present a longitudinal characterization of post-COVID-19 symptoms using social media data from Twitter. Using a combination of machine learning, natural language processing techniques, and clinician reviews, we mined 296,154 tweets to characterize the post-acute infection course of the disease, creating detailed timelines of symptoms and conditions, and analyzing their symptomatology during a period of over 150 days.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJMB was funded by a grant by the National Institute of Aging (3P30AG059307-02S1). DPA is funded through an NIHR Senior Research Fellowship (Grant number SRF-2018-11-ST2-004). VH contribution to this work was carried out with support from National Library of Medicine, National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB not neededAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available after formal publication.